Screener
Generate Biomedicines, Inc. GENB Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Generate Biomedicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Generate Biomedicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336437
FAQ
- What is Generate Biomedicines, Inc.'s total equity?
- Generate Biomedicines, Inc. (GENB) reported total equity of $456.05M in Q2 2026.
- How has Generate Biomedicines, Inc.'s total equity changed year-over-year?
- Generate Biomedicines, Inc.'s total equity increased by 188.1% year-over-year, from -$517.85M to $456.05M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Generate Biomedicines, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude